Back

Likely role of promoter reconstitution in Mpr-mediated D29 resistance by Mycobacterium smegmatis

Yusuf, B.; Ju, Y.; zhou, B.; Malik, A.; Alam, M. S.; Li, L.; Abraha, H. T.; BELACHEW, A. M.; Fang, C.; Tian, X.; Chen, H.; Wan, L.; Feng, L.; Xiong, X.; Wang, S.; Zhang, T.

2026-03-02 microbiology
10.64898/2026.02.27.708680 bioRxiv
Show abstract

The multi-copy phage resistance gene (mpr) of M. smegmatis is a major factor in resistance to the lytic mycobacteriophage D29. Mpr is a membrane-bound exonuclease that cleaves phage DNA post injection, hence blocking downstream stages in the phage infection cycle. The mechanism of resistance allows for adsorption, is non-abortive and independent of any mutation in the gene. Rather, it depends on overexpression of a wild type copy of the gene. However, the underlying factor behind mpr overexpression in spontaneous D29-resistant mutants of M. smegmatis remained elusive. Here, we report that D29 infection triggers insertion sequence (IS) rearrangements, including the transposition and integration of IS6120 directly upstream of mpr. Mutants with IS6120 integration upstream of mpr show highly elevated Mpr expression. Whole genome sequence analysis reveals that IS6120 introduced a putative transcription factor-binding site and a canonical -35 promoter element at the integration site, hence reconstituting a fuller promoter (rcp) than the original promoter (wtp) at the site. Promoter reporter assays suggest that rcp is a far stronger promoter than wtp, implying that elevated mpr expression in D29-resistant mutants with this transposition event could be due to promoter reconstitution. While strains with this transposition event appear to grow normally, rcp-driven, vector-borne Mpr overexpression appears to be toxic as it barely allows for colony formation on agar plates. This study reports a previously unknown factor likely behind mpr regulation in M. smegmatis, adding to the existing knowledge of mycobacterial anti-phage defense mechanisms and guiding rational phage engineering efforts for therapeutic applications.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Molecular Microbiology
66 papers in training set
Top 0.1%
12.3%
2
mBio
750 papers in training set
Top 1%
12.3%
3
PLOS Pathogens
721 papers in training set
Top 1%
10.1%
4
PLOS Genetics
756 papers in training set
Top 1%
10.1%
5
Nucleic Acids Research
1128 papers in training set
Top 2%
10.1%
50% of probability mass above
6
Microbial Genomics
204 papers in training set
Top 0.4%
4.8%
7
mSystems
361 papers in training set
Top 2%
4.0%
8
Nature Communications
4913 papers in training set
Top 40%
3.6%
9
Environmental Microbiology
119 papers in training set
Top 1%
2.6%
10
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 2%
2.6%
11
Journal of Bacteriology
190 papers in training set
Top 0.4%
2.1%
12
Microbiology Spectrum
435 papers in training set
Top 2%
2.1%
13
mSphere
281 papers in training set
Top 3%
1.9%
14
Frontiers in Microbiology
375 papers in training set
Top 5%
1.9%
15
PLOS Biology
408 papers in training set
Top 9%
1.8%
16
Cell Reports
1338 papers in training set
Top 27%
1.3%
17
Microbiological Research
19 papers in training set
Top 0.4%
1.2%
18
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 40%
0.9%
19
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 1%
0.9%
20
eLife
5422 papers in training set
Top 56%
0.8%
21
Microbiology
57 papers in training set
Top 1%
0.7%
22
Cell Host & Microbe
113 papers in training set
Top 5%
0.7%
23
iScience
1063 papers in training set
Top 37%
0.6%
24
Molecular Biology and Evolution
488 papers in training set
Top 5%
0.6%
25
Nature Microbiology
133 papers in training set
Top 5%
0.6%